Olanzapine tablets for the treatment of insomnia need to be specifically analyzed according to the condition, usually take a gradual reduction of the way to gradually stop the drug.
The drug is a psychotropic blocker, an antipsychotic drug, because of its sedative effect, especially suitable for patients suffering from schizophrenia accompanied by insomnia. Clinically the drug is used for the treatment of schizophrenia, the treatment of moderate to severe manic episodes, and the prevention of relapse of bipolar disorder.
There are adverse reactions such as dizziness, drowsiness, dry mouth, fatigue, arthralgia, and rash after using the drug.
It is contraindicated in patients who are allergic to any component of the drug; in patients with narrow-angle glaucoma.
Patients should be closely monitored during the course of treatment; caution should be exercised in patients with a history of convulsive seizures or factors that lower the threshold for convulsions; patients’ blood pressure should be monitored regularly during the course of the drug.
The drug treatment of insomnia need to stop the drug, should be given in the specialist physician’s assessment and monitoring of the scientific standardization of drug discontinuation, to prevent the emergence of drug withdrawal reaction and fluctuations in the condition, do not stop the drug on their own.